Bayer Yakuhin Sales Up 16.5% Driven by New Product Growth

Bayer Yakuhin President Carsten Brunn Bayer Yakuhin posted sales of 221.5 billion yen in 2013, up 16.5% from the previous year thanks to growth of its new product Xarelto (rivaroxaban), mainstay Zetia (ezetimibe), and other products, President Carsten Brunn said...read more